This course has expired. View available courses.
Oncology
Targeted therapeutic approaches in chronic lymphocytic leukaemia (CLL)
This continuing medical education program is designed to provide haematologists with an up-to-date approach to the management of chronic lymphocytic leukaemia, with the aim of optimising outcomes for their patients.
The program has an emphasis on the role of emerging pharmacotherapies such as venetoclax on outcomes for patients with CLL, including the data on relapse rates and progression-free survival.
This program was sponsored by an independent educational grant provided by Abbvie.
Abbvie has had no input into its content. The interviews and opinions expressed do not necessarily reflect those of the sponsor.
DURATION
1 hr
PROFESSION
Specialist
# OF CREDITS
1
ACCREDITATION
RACP
EXPIRY DATE
2023-03-02
This continuing medical education program is designed to provide haematologists with an up-to-date approach to the management of chronic lymphocytic leukaemia, with the aim of optimising outcomes for their patients.
The program has an emphasis on the role of emerging pharmacotherapies such as venetoclax on outcomes for patients with CLL, including the data on relapse rates and progression-free survival.
This program was sponsored by an independent educational grant provided by Abbvie.
Abbvie has had no input into its content. The interviews and opinions expressed do not necessarily reflect those of the sponsor.
Faculty
Dr Mary Ann Anderson,
Walter and Eliza Hall Institute, Melbourne
Learning objectives
On completion of this program, participants will be better able to:
- Describe the underlying biology of chronic lymphocytic leukaemia (CLL) including its ability to avoid cell death (through apoptosis) by upregulation of BCL-2
- Describe the impact of triggering apoptosis through BCL-2 inhibition on the clinical course of CLL
- Identify the role of emerging pharmacotherapies such as venetoclax on outcomes for patients with CLL, including the data on relapse rates and progression-free survival
- Compare the short-term and long-term toxicity profiles of venetoclax vs. chemoimmunotherapy and other agents
- Counsel patients and colleagues on the features of venetoclax, such as mode of administration, toxicity profile, and identify a dosing schedule to maximise patient safety and drug efficacy.
Accreditation
#
of credits: 1
Duration: 1 hr
FAQs & HELP
MDBriefCase Group specializes in accredited, online continuing professional development (CPD) programs, custom tailored for specific international markets and available on a convenient online platform.
All content is developed by leading specialists and peer-reviewed by experts at respected institutions, which keeps more than 280,000 global healthcare professionals at the forefront of the latest evidence and protocols worldwide.
The vast majority of our programs are accredited by one or more respected institutions. We do provide unaccredited content to ensure that healthcare professionals have access to relevant practical resources in addition to accredited learning.
Specific accrediting information (including the accrediting body, along with the type and number of credits) can be found on the “Main” page and/or “Accreditation” page of each program. In order to qualify for accreditation and obtain your certificate, you must successfully complete the requirements listed on the “Accreditation” or “CME Information” pages available in each program.
MDBriefCase Group works with various institutions to provide peer-reviewed, up-to-date accredited content. Our programs and resources are provided via collaboration between medical writers, faculty members, associations, universities and other relevant organizations. The content you were recommended is likely valued by your society or association and is conveniently provided to you free of charge on an MDBriefCase Group platform.
Specific accrediting information (including the accrediting body, along with the type and number of credits) can be found on the “Main” page and/or “Accreditation” page of each program. In order to qualify for accreditation and obtain your certificate, you must successfully complete the requirements listed on the “Accreditation” or “CME Information” pages available in each program.
If you are interested in learning more about supporting one of our programs, please contact us.
If you are interested in working with MDBriefCase Group as a writer or committee member, please contact us.
To access the MDBriefCase Group privacy policy, please click here.
No, registration with MDBriefCase is free!
To access your profile, visit My Profile. If you would like to update the information here don’t forget to hit the ‘save’ button when you are finished. Your profile is where you can control what email communications you receive.
If you have forgotten your password, you can reset your password. To access this page from the Login page, click Forgot password. Enter the email address you registered with and you will receive an email with a link to reset your password.
Please note: if you submitted multiple password resets, only the link on the most recent email is valid.
You can unsubscribe from MDBriefCase Group emails by clicking the unsubscribe button located at the bottom of each of our emails.
